SK to Invest $200 mln in Roivant’s Targeted Protein Degradation Platform

SEOUL, Dec. 7 (Korea Bizwire) — SK Holdings Co., an investment arm of South Korean conglomerate SK Group, said Monday it has signed a strategic partnership deal with U.S. biopharmaceutical firm Roivant Sciences Ltd. to enter the targeted protein degradation drug market. Under the deal, SK will invest US$200 million into Roivant’s targeted protein degradation [...]